Pfizer Stock Surges 099% on 712 Billion Trading Volume Ranking 97th in Market Activity

On June 6, 2025, Pfizer (PFE) experienced a 0.99% increase in its stock price, with a trading volume of 7.12 billion, ranking 97th in the day's market activity.

Pfizer's stock price has been influenced by several factors. The company, along with Arvinas, submitted a New Drug Application, which has garnered positive analyst sentiment. This submission has contributed to the bullish outlook on Pfizer's stock, as highlighted by a "Still a Buy?" recommendation from MarketBeat.

Pfizer's stock is currently trading at a significant discount to its estimated fair value, with earnings forecasted to grow at an annual rate of 7.24%. The company became profitable this year, which has also contributed to the positive sentiment surrounding its stock.

Additionally, Pfizer's stock is seen as a value play, trading at less than eight times forward earnings and offering a yield of over 7.2%. This makes it an attractive option for investors looking for undervalued stocks with strong growth potential.